Phibro Animal Health (PAHC) Change in Account Payables (2013 - 2026)
Phibro Animal Health (PAHC) recorded quarterly Change in Account Payables of -$2.9 million in Q1 2026, down 490.7% quarter-over-quarter from $753000.0 in Q4 2025, and down 110.39% on a YoY basis from $28.3 million in Q1 2025.
Phibro Animal Health (PAHC) Change in Account Payables (2013 - 2026) Analysis & Trends
Phibro Animal Health's Change in Account Payables history runs 14 years deep, the most recent figure standing at -$2.9 million for Q1 2026.
- In Q1 2026, Change in Account Payables fell 110.39% year-over-year to -$2.9 million; the TTM figure through Mar 2026 stood at -$4.2 million (down 108.96% YoY), while the FY2025 annual figure was $45.6 million, up 279.62% from the prior year.
- Change in Account Payables was -$2.9 million for Q1 2026 at Phibro Animal Health, down from $753000.0 in the prior quarter.
- In the past five years, Change in Account Payables ranged from a high of $28.3 million in Q1 2025 to a low of -$9.0 million in Q4 2022.
- Historically, Change in Account Payables has averaged $2.4 million across 5 years, with a median of $1.3 million in 2024.
- Biggest YoY gain for Change in Account Payables was 1409.44% in 2022; the steepest drop was 1188.52% in 2022.
- A 5-year view of Change in Account Payables shows it stood at -$9.0 million in 2022, then jumped by 176.95% to $6.9 million in 2023, then soared by 91.74% to $13.3 million in 2024, then slumped by 94.34% to $753000.0 in 2025, then tumbled by 490.7% to -$2.9 million in 2026.
- The last three Change in Account Payables figures came in at -$2.9 million (Q1 2026), $753000.0 (Q4 2025), and -$4.6 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Account Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | - |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 62.00 Mn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | - |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | - |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | - |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | - |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | 167.64 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 190,000.00 |
| 10 | Phibro Animal Health | 1.32 Bn | 1.24 Bn | 125.68 Mn | -2.94 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -2.94 Mn |
| Mar 31, 2026 | -2.94 Mn |
| Dec 31, 2025 | 753,000.00 |
| Dec 31, 2025 | 753,000.00 |
| Sep 30, 2025 | -4.63 Mn |
| Sep 30, 2025 | -4.63 Mn |
| Jun 30, 2025 | 2.62 Mn |
| Jun 30, 2025 | 2.62 Mn |
| Mar 31, 2025 | 28.33 Mn |
| Mar 31, 2025 | 28.33 Mn |
| Dec 31, 2024 | 13.31 Mn |
| Dec 31, 2024 | 13.31 Mn |
| Sep 30, 2024 | 1.30 Mn |
| Sep 30, 2024 | 1.30 Mn |
| Jun 30, 2024 | 3.90 Mn |
| Jun 30, 2024 | 3.90 Mn |
| Mar 31, 2024 | -3.44 Mn |
| Mar 31, 2024 | -3.44 Mn |
| Dec 31, 2023 | 6.94 Mn |
| Dec 31, 2023 | 6.94 Mn |